Lung Cancer
- Metabolic Syndrome Linked to Risk for Lung Cancer, Especially in Women
- OSE2101 Vaccine Outperforms Standard Care in Certain Patients With NSCLC
- Intensity-Modulated Radiation Therapy Best for Locally Advanced NSCLC
- Cardiovascular Events After ICI Therapy “Common” in Lung Cancer
- COPD Worsens Early Lung Cancer Symptoms but Improves Odds for Palliative Care
- COVID-19 Vaccines Increase PD-L1 Levels, Might Reverse Treatment Resistance in NSCLC
- Adding Nivolumab to SABR Improves EFS in NSCLC
- Lung Cancer Patients Have High Burden of COVID-19 Death in Omicron Era
- Tepotinib Plus Osimertinib May Provide Chemo-Free Option for NSCLC After First-Line Osimertinib
- Perioperative Durvalumab Does Not Impact Surgical Outcomes in NSCLC
- Adding Medication to Longitudinal Smoking Cessation Program Had No Benefit
- Lung Cancer Lymph Node Malignancy Predicted by Standardized Uptake, Node Size
Clinical Tools
Powered by
Powered by 
